2m 2m 2m 2m 2m 2m 2m
Aptargroup (ATR)
NYSE
$120.00+$0.01 (+0.008%)
Price as of Jun 17, 2026 5:48 PM EDT- $7.7BMarket Cap
- -18.69%1-Year Change
- Medical Instruments & SuppliesIndustry
Aptargroup (ATR)
$120.00+$0.01 (+0.008%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.8B +5.42% | 3.6B +2.74% | 3.5B +4.97% | 3.3B +2.94% | |
Cost of Revenue | 2.4B +184.26% | 834.6M N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.4B -48.89% | 2.7B -21.19% | 3.5B +4.97% | 3.3B +2.94% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -105.1M +9.37% | -96.1M +3.56% | -92.8M -199.25% | 93.5M -6.31% | |
Depreciation and Amortization Expense | 242.3M +10.31% | 219.7M +7.75% | 203.9M +7.23% | 190.1M -1.88% | |
Total Operating Expenses | 3.3B +6.15% | 3.1B +0.10% | 3.1B +4.77% | 2.9B +2.19% | |
Operating Profit | 501.0M +0.91% | 496.5M +22.89% | 404.0M +6.52% | 379.3M +9.19% | |
Interest Income | 11.7M -3.51% | 12.1M +176.72% | 4.4M +61.96% | 2.7M -26.39% | |
Interest Expense | N/A N/A | 0 +100.00% | -40.4M -1.00% | -40.8M +34.81% | |
Interest Income and Expense and Net | 11.7M -3.51% | 12.1M +133.57% | -36.0M -1,435.00% | 2.7M -26.39% | |
Total Nonoperating Income and Expense | -2.0M -162.08% | 3.3M +1.65% | 3.2M +166.93% | -4.8M +55.11% | |
Income before Taxes | 491.4M +4.60% | 469.8M +25.33% | 374.8M +11.99% | 334.7M +4.06% | |
Income Taxes | 98.9M +3.45% | 95.6M +5.45% | 90.6M -4.73% | 95.1M +21.96% | |
Extraordinary Items | 2.2M +764.96% | 254,000 -1.17% | 257,000 -16.29% | 307,000 -18.35% | |
Net Income | 392.8M +4.87% | 374.5M +31.65% | 284.5M +18.89% | 239.3M -1.79% | |
Net Income from Continuing Operations Applicable to Common | 491.4M +4.60% | 469.8M +25.33% | 374.8M +11.99% | 334.7M +37.12% | |
Basic EPS and Net Income | 5.97 +5.66% | 5.65 +30.18% | 4.34 +18.58% | 3.66 -1.61% | |
Diluted EPS and Net Income | 5.89 +6.51% | 5.53 +30.12% | 4.25 +18.38% | 3.59 -0.55% | |
Basic Weighted Average Shares | 65.7M -0.90% | 66.3M +1.09% | 65.6M +0.33% | 65.4M -0.40% | |
Diluted Weighted Average Shares | 66.7M -1.43% | 67.7M +1.17% | 66.9M +0.28% | 66.7M -1.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 402.4M +79.78% | 223.8M +0.09% | 223.6M +57.79% | 141.7M +15.30% | |
Short-Term Investments | 7.1M +204.19% | 2.3M N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 409.5M +81.06% | 226.2M +1.13% | 223.6M +57.79% | 141.7M +14.61% | |
Total Current Assets | 1.9B +28.08% | 1.5B -4.58% | 1.5B +8.32% | 1.4B +5.31% | |
Accumulated Depreciation | 2.9B +17.09% | 2.5B -0.32% | 2.5B +7.74% | 2.3B +2.49% | |
Property and Plant and Equipment and Net | 1.7B +15.85% | 1.4B -2.09% | 1.5B +10.00% | 1.3B +5.31% | |
Total Long-Term Assets | 1.7B +11.68% | 1.5B +5.77% | 1.4B -0.35% | 1.4B -5.16% | |
Total Assets | 5.3B +18.51% | 4.4B -0.44% | 4.5B +5.91% | 4.2B +1.50% | |
Income Taxes Payable | 19.6M +37.80% | 14.3M -25.02% | 19.0M -7.52% | 20.6M -25.35% | |
Total Short-Term Debt | 343.5M +1.55% | 338.3M -26.17% | 458.2M +273.17% | 122.8M -57.60% | |
Total Current Liabilities | 1.2B +9.19% | 1.1B -14.63% | 1.3B +36.43% | 917.2M -6.65% | |
Total Long-Term Debt | 1.1B +65.60% | 688.1M +1.01% | 681.2M -35.29% | 1.1B +16.05% | |
Total Long-Term Liabilities | 87.2M +11.51% | 78.2M -6.08% | 83.3M -0.92% | 84.1M -18.46% | |
Total Liabilities | 1.2B +8.62% | 1.1B -13.77% | 1.3B +35.04% | 960.1M -6.83% | |
Retained Earnings | 2.6B +11.47% | 2.4B +12.36% | 2.1B +9.36% | 1.9B +7.81% | |
Total Stockholders Equity | 2.7B +7.94% | 2.5B +7.16% | 2.3B +12.31% | 2.1B +4.29% | |
Total Shares Outstanding | 72.8M +0.41% | 72.5M +1.12% | 71.7M +1.27% | 70.8M +0.57% | |
Cash Flow | |||||
Cash from Operating Activities | 570.0M -11.41% | 643.4M +11.85% | 575.2M +20.19% | 478.6M +31.69% | |
Capital Expenditures | 270.4M -2.19% | 276.5M -11.48% | 312.3M +0.62% | 310.4M +0.81% | |
Cash from Investing Activities | -331.4M -16.46% | -396.7M +22.27% | -324.5M +9.75% | -295.6M -35.34% | |
Dividends Paid | 120.8M +5.90% | 114.1M +10.00% | 103.7M +4.24% | 99.5M +0.97% | |
Cash from Financing Activities | -77.5M -65.62% | -225.3M +31.35% | -171.6M +5.83% | -162.1M +98.85% | |
Financials Ratio | |||||
Gross Margin | 37.19% -51.52% | 76.71% N/A | N/A N/A | N/A N/A | |
Operating Margin | 13.26% -4.28% | 13.86% +19.62% | 11.58% +1.48% | 11.42% +6.07% | |
Return on Assets | 8.11% -3.80% | 8.43% +28.26% | 6.57% +14.62% | 5.74% -4.30% | |
Return on Equity | 15.28% -2.50% | 15.68% +20.14% | 13.05% +9.69% | 11.90% -6.75% | |
Revenue Growth | 5.42% +98.15% | 2.74% -44.96% | 4.97% +68.87% | 2.94% -71.04% | |
Current Ratio | 1.62 +17.31% | 1.38 +11.78% | 1.24 -20.61% | 1.56 +12.81% | |
Cash Ratio | 0.35 +64.68% | 0.21 +17.24% | 0.18 +15.66% | 0.15 +23.50% | |
Debt-to-Equity Ratio | 0.56 +33.86% | 0.42 -15.93% | 0.49 -13.70% | 0.57 -5.81% | |
Debt-to-Assets Ratio | 0.28 +21.89% | 0.23 -9.50% | 0.26 -8.48% | 0.28 -3.25% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow